Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Surgery Open Science
|
September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program
Jonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Mark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Investigational New Drugs
|
March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma
Steven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or Lymphomas
Kevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer
Hossein Borghaei, Corey J Langer, Shirish Gadgeel, et al.
The Lancet. Oncology
|
October 18, 2016
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J Langer, Shirish M Gadgeel, Hossein Borghaei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2023
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
Marina C Garassino, Shirish Gadgeel, Giovanna Speranza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Steven F Powell, Kathryn A Gold, Mark M Gitau, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Surgery Open Science
|
September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program
Jonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2021
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Mark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Investigational New Drugs
|
March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma
Steven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or Lymphomas
Kevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer
Hossein Borghaei, Corey J Langer, Shirish Gadgeel, et al.
The Lancet. Oncology
|
October 18, 2016
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J Langer, Shirish M Gadgeel, Hossein Borghaei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2023
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
Marina C Garassino, Shirish Gadgeel, Giovanna Speranza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Steven F Powell, Kathryn A Gold, Mark M Gitau, et al.
JCO Precision Oncology
|
February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study
Steven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Page
of 3